Respinova Ltd.
Pressure-pulsation home-use device for managing COPD
This article was originally published in Start Up
Executive Summary
Respinova Ltd. has developed a noninvasive home-use device to help patients manage COPD’s debilitating symptoms. The PulseHaler is similar to continuous positive airway pressure devices used for sleep apnea, but it is designed to treat the very small terminal airways that are blocked as a result of COPD.
You may also be interested in...
Doc On Call? Cosmetic Manufacturers May Need M.D. On Retainer Under MoCRA
Cosmetic manufacturers may need to retain a medical professional to determine if adverse events they receive are minor or serious given the looming deadline for maintaining records and reporting serious adverse events to the US FDA, says Locke Lord partner David Abramowitz.
AstraZeneca/Sanofi’s Nirsevimab Nears US FDA Approval After Overwhelmingly Positive Adcomm
When patients should receive the RSV prevention treatment was the subject of much debate even as the Antimicrobial Drugs Advisory Committee voted nearly unanimously that it should be approved for infants and neonates.